<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Sophiris Bio, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Sophiris Bio, Inc.

    Sophiris Bio Inc. is a late-stage biopharmaceutical company developing topsalysin (PRX302) for the treatment of patients with urological diseases. Topsalysin is in Phase 2 clinical development for the focal treatment of localized prostate cancer as well as Phase 3 clinical development for the treatment of lower urinary tract symptoms of benign prostatic hyperplasia (BPH). Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $80,700,000
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Randall E. Woods
    • FOUNDED
      2002
    • EMPLOYEES
      0-10
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Aeolus Pharmaceuticals, Inc.

    Aeolus Pharmaceuticals, Inc.

    Aeolus Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses o...

    Aeolus Pharmaceuticals, Inc. is a biopharmaceut...

    Amount Raised:    $18,500,000
    Fundraising Status:    VT
    Filing Type:    PU
    Angle PLC

    Angle PLC

    ANGLE is a world leading liquid biopsy company with pioneering products in cancer ...

    ANGLE is a world leading liquid biopsy company ...

    Amount Raised:    $250,000
    Fundraising Status:    VT
    Filing Type:    PU
    Establishment Labs Holdings Inc.

    Establishment Labs Holdings Inc.

    Establishment Labs is a global medical technology company focused on improving pat...

    Establishment Labs is a global medical technolo...

    Filing Type:    PU
    Marker Therapeutics, Inc.

    Marker Therapeutics, Inc.

    We are a clinical-stage immuno-oncology company specializing in the development an...

    We are a clinical-stage immuno-oncology company...

    Filing Type:    PU
    Aurinia Pharmaceuticals Inc

    Aurinia Pharmaceuticals Inc

    Aurinia is a late clinical stage biopharmaceutical company focused on developing a...

    Aurinia is a late clinical stage biopharmaceuti...

    Filing Type:    PU
    Milestone Pharmaceuticals Inc.

    Milestone Pharmaceuticals Inc.

    We are a patient-centric, clinical-stage biopharmaceutical company dedicated to br...

    We are a patient-centric, clinical-stage biopha...

    Filing Type:    PU
    Trevi Therapeutics, Inc.

    Trevi Therapeutics, Inc.

    We are developing nalbuphine ER to treat serious neurologically mediated condition...

    We are developing nalbuphine ER to treat seriou...

    Filing Type:    PU
    Neurotez Inc.

    Neurotez Inc.

    We have used biochemical, molecular & cell biology and in vivo models to screen, i...

    We have used biochemical, molecular & cell biol...

    Amount Raised:    $7,656.00
    Fundraising Status:    EC
    Filing Type:    CF
    Biogen Inc.

    Biogen Inc.

    At Biogen, our mission is clear: we are pioneers in neuroscience. Biogen discovers...

    At Biogen, our mission is clear: we are pioneer...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.